Results 131 to 140 of about 201,440 (215)

[Corrigendum] CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. [PDF]

Int J Oncol
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X, Xu ZF, Sun CF.   +6 more
europepmc   +1 more source

Definitive treatment in squamous cell carcinoma of head and neck: A retrospective analysis of chemoradiotherapy in a university hospital setting. [PDF]

Braz J Otorhinolaryngol
Sousa HSV, Horita VN, Novaes DML, Perin MY, Teixeira DNA, Gruenwaldt J, Pereira EB, Chone CT, Lourenço GJ, Macedo LT, Lima CSP.   +10 more
europepmc   +1 more source

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States. [PDF]

Health Qual Life Outcomes, 2020
Aggarwal H, Punekar RS, Li L, Carter GC, Walker MS.   +4 more
europepmc   +1 more source

High-Sensitivity PD-L1 Staining Using Clone 73-10 Antibody and Spatial Transcriptomics for Precise Expression Analysis in Non-Tumorous, Intraepithelial Neoplasia, and Squamous Cell Carcinoma of Head and Neck. [PDF]

Head Neck Pathol
Noda Y, Atsumi N, Nakaya T, Iwai H, Tsuta K.   +4 more
europepmc   +1 more source

Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO. [PDF]

Open Med (Wars), 2020
Zhao L, Tian C, Xiao E, Du J, Liang J, Chen X, Chi W.   +6 more
europepmc   +1 more source

Tumor thickness as a novel risk factor for lymph node metastasis by superficial squamous cell carcinoma of head and neck. [PDF]

Cancer Sci
Fujii S, Katada C, Watanabe H, Shimoda T, Ochiai A, Yokoyama T, Sakamoto Y, Kano K, Ichinoe M, Nemoto T, Fujita M, Tateishi Y, Sugiura H, Mikami T, Yano T, Kato T, Muto M, Hayashi R.   +17 more
europepmc   +1 more source

Porous polyethylene in reconstructive head and neck surgery [PDF]

, 1985
Berghaus, Alexander
core   +1 more source

Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. [PDF]

Braz J Otorhinolaryngol
Caballero-Borrego M, Piedra A, Gallego Ó, López-Pousa A, Castillo P, Navarrete P, Prat A, Grau JJ.   +7 more
europepmc   +1 more source

CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck. [PDF]

Chin J Cancer Res, 2019
Tang C, Lin L, Zhou W, Liu X, Fu Y, Zhang L, Li L, Wang X, Zhao L, Liang J.   +9 more
europepmc   +1 more source

Squamous cell carcinomas of the head and neck [PDF]

BMJ, 2003
openaire   +1 more source